Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026)
Biolife Solutions (BLFS) reported Return on Capital Employed of 3.99% for Q1 2026, down 353.0% year-over-year from 1.58% in Q1 2025, and up 5.61% quarter-over-quarter from 4.22% in Q4 2025.
Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 16 years of Return on Capital Employed data on file, last reported at 3.99% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 3.99%, down 353.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.99% (down 353.0% YoY), and the FY2025 annual result was 4.37%, down 317.0% from the prior year.
- Return on Capital Employed grew to 3.99% in Q1 2026 per BLFS's latest filing, from 4.22% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 13.59% in Q2 2023 and troughed at 26.14% in Q3 2022.
- A 5-year average of 3.62% and a median of 3.22% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed tumbled 2176 bps in 2022, then surged 3948 bps in 2023.
- A 5-year view of Return on Capital Employed shows it stood at 1.4% in 2022, then tumbled by 330 bps to 6.0% in 2023, then soared by 79 bps to 1.25% in 2024, then plunged by 238 bps to 4.22% in 2025, then increased by 6 bps to 3.99% in 2026.
- Business Quant data shows BLFS's Return on Capital Employed at 3.99% in Q1 2026, 4.22% in Q4 2025, and 4.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | -3.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.99% |
| Dec 31, 2025 | -4.22% |
| Sep 30, 2025 | -4.60% |
| Jun 30, 2025 | -4.69% |
| Mar 31, 2025 | -0.45% |
| Dec 31, 2024 | -1.25% |
| Sep 30, 2024 | 3.61% |
| Jun 30, 2024 | -0.71% |
| Mar 31, 2024 | -3.22% |
| Dec 31, 2023 | -6.00% |
| Sep 30, 2023 | 13.34% |
| Jun 30, 2023 | 13.59% |
| Mar 31, 2023 | -2.88% |
| Dec 31, 2022 | -1.40% |
| Sep 30, 2022 | -26.14% |
| Jun 30, 2022 | -24.23% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | -6.84% |
| Sep 30, 2021 | -4.38% |
| Jun 30, 2021 | -3.49% |